510(k) Report

510(k) · Cleared

Cleared

Max-Act

K983649510(k) TraditionalCleared Dec 11, 199856-day reviewClass II21 CFR 864.7140

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Array Medical, Inc. · JBP Activated Whole Blood Clotting Time

Cleared on Dec 11, 1998 as substantially equivalent to K964609 (Array Medical, Inc., 1997) after a 56-day review. Its family tree reaches back 1 generation to 1997.

Decided
Dec 11, 1998
Review
56 days
Class
Class II
Product code
JBP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K964609 (1997). No later device cites it as a predicate yet.

  1. Root · 1 generation backK964609 Actalyke Activated Clotting Time Test System/Clotting Time…Array Medical, Inc. · 1997
  2. This deviceK983649 Max-ActArray Medical, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K964609Actalyke Activated Clotting Time Test System/Clotting Time Tubes/Whole Blood…Array Medical, Inc.1997—
0 (this device)K983649Max-ActArray Medical, Inc.1998—
FIG. 1 — Lineage of K983649, 1997–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JBP device

  1. #1 K223635 Sonoclot Coagulation & Platelet Function…score 4.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964609Actalyke Activated Clotting Time Test System/Clotting Time Tubes/Whole Blood QC…
Summary page 1
…mon Name: Activated clotting time test Classification Name: Activated whole blood clotting time tests Legally Marketed Device: Array Medical Actalyke C-ACT test tube, K964609. Device Description: The MAX-ACT Activated Clotting Time test tubes utilize a “cocktail” of particulate activators (including c…
Array Medical, Inc.1997—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JBP devices

JBP Activated Whole Blood Clotting Time: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JBP

1in 2023

2007: 12023: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JBP

Too few JBP 510(k)s in any year since 2007 to give a median.

Recalls per year · JBP

2in 2025

2009: 32010: 32025: 2
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JBP

18in 2025

2007: 52008: 62009: 292010: 242011: 112012: 252013: 322014: 32015: 262016: 42017: 162018: 12019: 152020: 102021: 92022: 72023: 162024: 232025: 18
2007high 32 (2013) · low 1 (2018)2025

MAUDE reports naming product code JBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—05
20080—06
20090—329
20100—324
20110—011
20120—025
20130—032
20140—03
20150—026
20160—04
20170—016
20180—01
20190—015
20200—010
20210—09
20220—07
20231—016
20240—023
20250—218
20260—0—

What is it indicated for?

The MAX-ACT Activated Clotting Time test tubes are intended for the measurement of the activated clotting time (ACT) test on Actalyke Models Al, AIP, A2, A2P, and on Hemochron Models 400,401,800,801, and 8000.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983649: Max-Act.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K983649

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026